These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 44806)

  • 1. [Treatment with high doses of neuroleptics in the acute phase of mental diseases].
    Dencker SJ
    Acta Psiquiatr Psicol Am Lat; 1979 Jun; 25(2):157-60. PubMed ID: 44806
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptics in the aged].
    Tatarelli R; Tartaglini L
    Clin Ter; 1983 Jul; 106(1):47-64. PubMed ID: 6138178
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose treatment with neuroleptics in the acute phase of mental disease.
    Dencker SJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):32-4. PubMed ID: 14332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
    Barr AM; Honer WG; Johnson JL; Wu TK; Procyshyn RM
    J Clin Psychopharmacol; 2010 Dec; 30(6):741-3. PubMed ID: 21057241
    [No Abstract]   [Full Text] [Related]  

  • 6. Mental health emergencies. Zuclopenthixol acetate is given by intramuscular injection, not intravenously.
    Orange-Bromehead R
    BMJ; 1997 Oct; 315(7112):885. PubMed ID: 9353526
    [No Abstract]   [Full Text] [Related]  

  • 7. [When does the extrapyramidal syndrome become an adverse reaction to major psychotropic drugs? ].
    Csiky K
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(2):131-4. PubMed ID: 30159
    [No Abstract]   [Full Text] [Related]  

  • 8. Some aspects of the French contribution during the past ten years to the study and use of injectable long-acting neuroleptics.
    Lambert PA; Guinot G; Chabannes JP
    Acta Psychiatr Belg; 1981; 81(2):103-14. PubMed ID: 6117180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpatient variations in antipsychotic therapy.
    McIntyre IM; Gershon S
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):3-5. PubMed ID: 2859279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment strategies of psychotic states using low-dose neuroleptics: immediate and long-term course].
    Schmitt L; Lemaire A; Lefranc G; Febrer A; Moron P
    Ann Med Psychol (Paris); 1988; 146(1-2):119-23. PubMed ID: 2901243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 12. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
    Costentin J
    Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy.
    Khanna R
    Aust N Z J Psychiatry; 1995 Dec; 29(4):691-2; author reply 692-3. PubMed ID: 8825836
    [No Abstract]   [Full Text] [Related]  

  • 16. A critical evaluation of molindone (Moban): a new indole derivative neuroleptic.
    Ayd FJ
    Dis Nerv Syst; 1974 Oct; 35(10):447-52. PubMed ID: 17894057
    [No Abstract]   [Full Text] [Related]  

  • 17. Focal neuroleptization: an approach to optimal dosing for initial and continuing therapy.
    Tupin JP
    J Clin Psychopharmacol; 1985 Jun; 5(3 Suppl):15S-21S. PubMed ID: 2860138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with leptril therapy for preschool children].
    Semenovskaia EI; Rozengauz RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1579-82. PubMed ID: 4149525
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaceutical characteristics of depot neuroleptics. Their use and efficacy in the psychiatric clinic].
    Mungiu OC; Chiriţă V; Boişteanu P; Mungiu A; Cosmovici N; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):43-7. PubMed ID: 2899341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.